{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:25:52Z","timestamp":1793834752490,"version":"4.6.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82495174"],"award-info":[{"award-number":["82495174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949201"],"award-info":[{"award-number":["91949201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801062"],"award-info":[{"award-number":["81801062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421081"],"award-info":[{"award-number":["242300421081"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1038\/s41380-026-03740-y","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:09:19Z","timestamp":1783922959000},"page":"6774-6792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PIAS1-mediated GSK3\u03b2 SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer\u2019s disease models"],"prefix":"10.1038","volume":"31","author":[{"given":"Youlan","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangsong","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-5972","authenticated-orcid":false,"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-6950","authenticated-orcid":false,"given":"Enjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7121-0318","authenticated-orcid":false,"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"3740_CR1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ. Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741\u201366.","journal-title":"Physiol Rev"},{"key":"3740_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H 3rd. Alzheimer\u2019s disease and the amyloid-beta peptide. J Alzheimers Dis. 2010;19:311\u201323.","journal-title":"J Alzheimers Dis"},{"key":"3740_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jmb.2004.04.008","volume":"339","author":"RA Santarella","year":"2004","unstructured":"Santarella RA, Skiniotis G, Goldie KN, Tittmann P, Gross H, Mandelkow EM, et al. Surface-decoration of microtubules by human tau. J Mol Biol. 2004;339:539\u201353.","journal-title":"J Mol Biol"},{"key":"3740_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nrd2959","volume":"8","author":"KR Brunden","year":"2009","unstructured":"Brunden KR, Trojanowski JQ, Lee VM. Advances in tau-focused drug discovery for Alzheimer\u2019s disease and related tauopathies. Nat Rev Drug Discov. 2009;8:783\u201393.","journal-title":"Nat Rev Drug Discov"},{"key":"3740_CR5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807\u201319.","journal-title":"Lancet Neurol"},{"key":"3740_CR6","first-page":"38","volume":"9","author":"MZ Li","year":"2022","unstructured":"Li MZ, Liu EJ, Zhou QZ, Li SH, Liu SJ, Yu HT, et al. Intracellular accumulation of tau inhibits autophagosome formation by activating TIA1-amino acid-mTORC1 signaling. Mil Med Res. 2022;9:38.","journal-title":"Mil Med Res"},{"key":"3740_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-024-00397-x","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Tan Y, Zhang Z, Yi M, Zhu L, Peng W. The interaction between ageing and Alzheimer\u2019s disease: insights from the hallmarks of ageing. Transl Neurodegener. 2024;13:7.","journal-title":"Transl Neurodegener"},{"key":"3740_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102699","volume":"106","author":"F Bellelli","year":"2025","unstructured":"Bellelli F, Angioni D, Arosio B, Vellas B, De Souto Barreto P. Hallmarks of aging and Alzheimer\u2019s Disease pathogenesis: Paving the route for new therapeutic targets. Ageing Res Rev. 2025;106:102699.","journal-title":"Ageing Res Rev"},{"key":"3740_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17:5\u201321.","journal-title":"Nat Rev Neurosci"},{"key":"3740_CR10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0896-6273(03)00681-0","volume":"40","author":"DH Geschwind","year":"2003","unstructured":"Geschwind DH. Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? Neuron. 2003;40:457\u201360.","journal-title":"Neuron"},{"key":"3740_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrneurol.2017.162","volume":"14","author":"JC Polanco","year":"2018","unstructured":"Polanco JC, Li C, Bodea LG, Martinez-Marmol R, Meunier FA, Gotz J. Amyloid-beta and tau complexity - towards improved biomarkers and targeted therapies. Nat Rev Neurol. 2018;14:22\u201339.","journal-title":"Nat Rev Neurol"},{"key":"3740_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41580-022-00500-y","volume":"23","author":"ACO Vertegaal","year":"2022","unstructured":"Vertegaal ACO. Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol. 2022;23:715\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3740_CR13","doi-asserted-by":"crossref","first-page":"21122","DOI":"10.1073\/pnas.1215366110","volume":"109","author":"M Tirard","year":"2012","unstructured":"Tirard M, Hsiao HH, Nikolov M, Urlaub H, Melchior F, Brose N. In vivo localization and identification of SUMOylated proteins in the brain of His6-HA-SUMO1 knock-in mice. Proc Natl Acad Sci USA. 2012;109:21122\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3740_CR14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ymthe.2020.09.003","volume":"29","author":"YC Liu","year":"2021","unstructured":"Liu YC, Hsu WL, Ma YL, Lee EHY. Melatonin induction of APP intracellular domain 50 SUMOylation alleviates AD through enhanced transcriptional activation and abeta degradation. Mol Ther. 2021;29:376\u201395.","journal-title":"Mol Ther"},{"key":"3740_CR15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/cdd.2016.161","volume":"24","author":"CC Tao","year":"2017","unstructured":"Tao CC, Hsu WL, Ma YL, Cheng SJ, Lee EH. Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Abeta toxicity in a mouse model of Alzheimer\u2019s disease. Cell Death Differ. 2017;24:597\u2013614.","journal-title":"Cell Death Differ"},{"key":"3740_CR16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/bph.14656","volume":"176","author":"SY Liu","year":"2019","unstructured":"Liu SY, Ma YL, Hsu WL, Chiou HY, Lee EHY. Protein inhibitor of activated STAT1 Ser(503) phosphorylation-mediated Elk-1 SUMOylation promotes neuronal survival in APP\/PS1 mice. Br J Pharmacol. 2019;176:1793\u2013810.","journal-title":"Br J Pharmacol"},{"key":"3740_CR17","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.1704351114","volume":"114","author":"R Rott","year":"2017","unstructured":"Rott R, Szargel R, Shani V, Hamza H, Savyon M, Abd Elghani F, et al. SUMOylation and ubiquitination reciprocally regulate alpha-synuclein degradation and pathological aggregation. Proc Natl Acad Sci USA. 2017;114:13176\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3740_CR18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","volume":"304","author":"JS Steffan","year":"2004","unstructured":"Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, et al. SUMO modification of Huntingtin and Huntington\u2019s disease pathology. Science. 2004;304:100\u20134.","journal-title":"Science"},{"key":"3740_CR19","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1007\/s12035-022-02734-5","volume":"59","author":"H Takamura","year":"2022","unstructured":"Takamura H, Nakayama Y, Ito H, Katayama T, Fraser PE, Matsuzaki S. SUMO1 modification of tau in progressive supranuclear palsy. Mol Neurobiol. 2022;59:4419\u201335.","journal-title":"Mol Neurobiol"},{"key":"3740_CR20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.molcel.2020.10.032","volume":"80","author":"H Marmor-Kollet","year":"2020","unstructured":"Marmor-Kollet H, Siany A, Kedersha N, Knafo N, Rivkin N, Danino YM, et al. Spatiotemporal proteomic analysis of stress granule disassembly using APEX reveals regulation by SUMOylation and links to ALS pathogenesis. Mol Cell. 2020;80:876\u201391.e876.","journal-title":"Mol Cell"},{"key":"3740_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41418-025-01448-0","volume":"32","author":"L Wan","year":"2025","unstructured":"Wan L, Yang F, Yin A, Luo Y, Liu Y, Liu F, et al. Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer\u2019s disease. Cell Death Differ. 2025;32:837\u201354.","journal-title":"Cell Death Differ"},{"key":"3740_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-025-00826-z","volume":"20","author":"TR Suk","year":"2025","unstructured":"Suk TR, Part CE, Zhang JL, Nguyen TT, Heer MM, Caballero-Gomez A, et al. A stress-dependent TDP-43 SUMOylation program preserves neuronal function. Mol Neurodegener. 2025;20:38.","journal-title":"Mol Neurodegener"},{"key":"3740_CR23","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1111\/febs.15319","volume":"287","author":"AB Celen","year":"2020","unstructured":"Celen AB, Sahin U. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J. 2020;287:3110\u201340.","journal-title":"FEBS J"},{"key":"3740_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrm3011","volume":"11","author":"JR Gareau","year":"2010","unstructured":"Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 2010;11:861\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3740_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14581-w","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, McManus FP, Plutoni C, Pascariu CM, Nelson T, Alberici Delsin LE, et al. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility. Nat Commun. 2020;11:834.","journal-title":"Nat Commun"},{"key":"3740_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nature08657","volume":"462","author":"Y Galanty","year":"2009","unstructured":"Galanty Y, Belotserkovskaya R, Coates J, Polo S, Miller KM, Jackson SP. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature. 2009;462:935\u20139.","journal-title":"Nature"},{"key":"3740_CR27","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1007\/s00018-009-0061-z","volume":"66","author":"MM Rytinki","year":"2009","unstructured":"Rytinki MM, Kaikkonen S, Pehkonen P, Jaaskelainen T, Palvimo JJ. PIAS proteins: pleiotropic interactors associated with SUMO. Cell Mol Life Sci. 2009;66:3029\u201341.","journal-title":"Cell Mol Life Sci"},{"key":"3740_CR28","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1073\/pnas.95.18.10626","volume":"95","author":"B Liu","year":"1998","unstructured":"Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, et al. Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci USA. 1998;95:10626\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3740_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02124-6","volume":"23","author":"X Zang","year":"2024","unstructured":"Zang X, He XY, Xiao CM, Lin Q, Wang MY, Liu CY, et al. Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1. Mol Cancer. 2024;23:207.","journal-title":"Mol Cancer"},{"key":"3740_CR30","doi-asserted-by":"crossref","first-page":"9574","DOI":"10.1523\/JNEUROSCI.4302-13.2014","volume":"34","author":"YC Chen","year":"2014","unstructured":"Chen YC, Hsu WL, Ma YL, Tai DJ, Lee EH. CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory. J Neurosci. 2014;34:9574\u201389.","journal-title":"J Neurosci"},{"key":"3740_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-017-0452-9","volume":"15","author":"WL Hsu","year":"2017","unstructured":"Hsu WL, Ma YL, Liu YC, Lee EHY. Smad4 SUMOylation is essential for memory formation through upregulation of the skeletal myopathy gene TPM2. BMC Biol. 2017;15:112.","journal-title":"BMC Biol"},{"key":"3740_CR32","doi-asserted-by":"crossref","first-page":"22857","DOI":"10.1074\/jbc.M401554200","volume":"279","author":"M Liang","year":"2004","unstructured":"Liang M, Melchior F, Feng XH, Lin X. Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1. J Biol Chem. 2004;279:22857\u201365.","journal-title":"J Biol Chem"},{"key":"3740_CR33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.celrep.2013.06.034","volume":"4","author":"JG O\u2019Rourke","year":"2013","unstructured":"O\u2019Rourke JG, Gareau JR, Ochaba J, Song W, Rasko T, Reverter D, et al. SUMO-2 and PIAS1 modulate insoluble mutant huntingtin protein accumulation. Cell Rep. 2013;4:362\u201375.","journal-title":"Cell Rep"},{"key":"3740_CR34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neuron.2016.04.022","volume":"90","author":"Z He","year":"2016","unstructured":"He Z, Jin Y. Intrinsic control of axon regeneration. Neuron. 2016;90:437\u201351.","journal-title":"Neuron"},{"key":"3740_CR35","doi-asserted-by":"crossref","first-page":"e2021836118","DOI":"10.1073\/pnas.2021836118","volume":"118","author":"EL Morozko","year":"2021","unstructured":"Morozko EL, Smith-Geater C, Monteys AM, Pradhan S, Lim RG, Langfelder P, et al. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington\u2019s disease. Proc Natl Acad Sci USA. 2021;118:e2021836118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3740_CR36","doi-asserted-by":"crossref","first-page":"pdb prot5121","DOI":"10.1101\/pdb.prot5121","volume":"2009","author":"V Vethantham","year":"2009","unstructured":"Vethantham V, Manley JL. In vitro sumoylation of recombinant proteins and subsequent purification for use in enzymatic assays. Cold Spring Harb Protoc. 2009;2009:pdb prot5121.","journal-title":"Cold Spring Harb Protoc"},{"key":"3740_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2008.05.022","volume":"31","author":"P Knipscheer","year":"2008","unstructured":"Knipscheer P, Flotho A, Klug H, Olsen JV, van Dijk WJ, Fish A, et al. Ubc9 sumoylation regulates SUMO target discrimination. Mol Cell. 2008;31:371\u201382.","journal-title":"Mol Cell"},{"key":"3740_CR38","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3390\/cells11223629","volume":"11","author":"M Bose","year":"2022","unstructured":"Bose M, Farias Quipildor G, Ehrlich ME, Salton SR. Intranasal peptide therapeutics: a promising avenue for overcoming the challenges of traditional CNS drug development. Cells. 2022;11:3629.","journal-title":"Cells"},{"key":"3740_CR39","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/pharmaceutics16060774","volume":"16","author":"Y Yanamadala","year":"2024","unstructured":"Yanamadala Y, Roy R, Williams AA, Uppu N, Kim AY, DeCoster MA, et al. Intranasal delivery of cell-penetrating therapeutic peptide enhances brain delivery, reduces inflammation, and improves neurologic function in moderate traumatic brain injury. Pharmaceutics. 2024;16:774.","journal-title":"Pharmaceutics"},{"key":"3740_CR40","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1:848\u201358.","journal-title":"Nat Protoc"},{"key":"3740_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41392-024-01812-5","volume":"9","author":"X Wang","year":"2024","unstructured":"Wang X, Liu Q, Yu HT, Xie JZ, Zhao JN, Fang ZT, et al. A positive feedback inhibition of isocitrate dehydrogenase 3\u03b2 on paired-box gene 6 promotes Alzheimer-like pathology. Signal Transduct Target Ther. 2024;9:105.","journal-title":"Signal Transduct Target Ther"},{"key":"3740_CR42","volume":"381","author":"ZY Zhang","year":"2023","unstructured":"Zhang ZY, Harischandra DS, Wang R, Ghaisas S, Zhao JY, McMonagle TP, et al. TRIM11 protects against tauopathies and is down-regulated in Alzheimer\u2019s disease. Science. 2023;381:eadd6696.","journal-title":"Science"},{"key":"3740_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12929-022-00871-6","volume":"29","author":"BC Tong","year":"2022","unstructured":"Tong BC, Huang AS, Wu AJ, Iyaswamy A, Ho OK, Kong AH, et al. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies. J Biomed Sci. 2022;29:85.","journal-title":"J Biomed Sci"},{"key":"3740_CR44","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","volume":"100","author":"HM Chang","year":"2020","unstructured":"Chang HM, Yeh ETH. SUMO: from bench to bedside. Physiol Rev. 2020;100:1599\u2013619.","journal-title":"Physiol Rev"},{"key":"3740_CR45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.tibs.2003.09.002","volume":"28","author":"F Melchior","year":"2003","unstructured":"Melchior F, Schergaut M, Pichler A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci. 2003;28:612\u20138.","journal-title":"Trends Biochem Sci"},{"key":"3740_CR46","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/onc.2010.462","volume":"30","author":"Y Chu","year":"2011","unstructured":"Chu Y, Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene. 2011;30:1108\u201316.","journal-title":"Oncogene"},{"key":"3740_CR47","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1073\/pnas.87.15.5827","volume":"87","author":"SG Greenberg","year":"1990","unstructured":"Greenberg SG, Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA. 1990;87:5827\u201331.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3740_CR48","first-page":"e47202","volume":"20","author":"XG Li","year":"2019","unstructured":"Li XG, Hong XY, Wang YL, Zhang SJ, Zhang JF, Li XC, et al. Tau accumulation triggers STAT1-dependent memory deficits by suppressing NMDA receptor expression. EMBO Rep. 2019;20:e47202.","journal-title":"EMBO Rep"},{"key":"3740_CR49","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cell.2007.03.056","volume":"129","author":"B Liu","year":"2007","unstructured":"Liu B, Yang Y, Chernishof V, Loo RR, Jang H, Tahk S, et al. Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell. 2007;129:903\u201314.","journal-title":"Cell"},{"key":"3740_CR50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.molcel.2009.07.021","volume":"35","author":"JH Lee","year":"2009","unstructured":"Lee JH, Park SM, Kim OS, Lee CS, Woo JH, Park SJ, et al. Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Mol Cell. 2009;35:806\u201317.","journal-title":"Mol Cell"},{"key":"3740_CR51","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","volume":"25","author":"ME Migaud","year":"2024","unstructured":"Migaud ME, Ziegler M, Baur JA. Regulation of and challenges in targeting NAD(+) metabolism. Nat Rev Mol Cell Biol. 2024;25:822\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3740_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","volume":"25","author":"C Parra Bravo","year":"2024","unstructured":"Parra Bravo C, Naguib SA, Gan L. Cellular and pathological functions of tau. Nat Rev Mol Cell Biol. 2024;25:845\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3740_CR53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Yardin C, et al. Tau protein kinases: involvement in Alzheimer\u2019s disease. Ageing Res Rev. 2013;12:289\u2013309.","journal-title":"Ageing Res Rev"},{"key":"3740_CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj2960015","volume":"296","author":"C Sutherland","year":"1993","unstructured":"Sutherland C, Leighton IA, Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J. 1993;296:15\u20139.","journal-title":"Biochem J"},{"key":"3740_CR55","volume":"78","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Li S, Li M, Ke D, Wang Q, Yang Y, et al. Human tau accumulation promotes glycogen synthase kinase-3beta acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration. EBioMedicine. 2022;78:103970.","journal-title":"EBioMedicine"},{"key":"3740_CR56","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.2174\/1389557522666220420094317","volume":"22","author":"N Chauhan","year":"2022","unstructured":"Chauhan N, Paliwal S, Jain S, Verma K, Paliwal S, Sharma S. GSK-3beta and its inhibitors in Alzheimer\u2019s disease: a recent update. Mini Rev Med Chem. 2022;22:2881\u201395.","journal-title":"Mini Rev Med Chem"},{"key":"3740_CR57","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1046\/j.1471-4159.2003.02070.x","volume":"87","author":"SJ Liu","year":"2003","unstructured":"Liu SJ, Zhang AH, Li HL, Wang Q, Deng HM, Netzer WJ, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem. 2003;87:1333\u201344.","journal-title":"J Neurochem"},{"key":"3740_CR58","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/MCB.25.3.1113-1123.2005","volume":"25","author":"B Liu","year":"2005","unstructured":"Liu B, Yang R, Wong KA, Getman C, Stein N, Teitell MA, et al. Negative regulation of NF-kappaB signaling by PIAS1. Mol Cell Biol. 2005;25:1113\u201323.","journal-title":"Mol Cell Biol"},{"key":"3740_CR59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2015;148:114\u201331.","journal-title":"Pharmacol Ther"},{"key":"3740_CR60","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1093\/brain\/awad159","volume":"146","author":"KP Kepp","year":"2023","unstructured":"Kepp KP, Robakis NK, Hoilund-Carlsen PF, Sensi SL, Vissel B. The amyloid cascade hypothesis: an updated critical review. Brain. 2023;146:3969\u201390.","journal-title":"Brain"},{"key":"3740_CR61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"3740_CR62","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1097-2765(03)00175-8","volume":"11","author":"X Lin","year":"2003","unstructured":"Lin X, Sun B, Liang M, Liang YY, Gast A, Hildebrand J, et al. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell. 2003;11:1389\u201396.","journal-title":"Mol Cell"},{"key":"3740_CR63","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1097-2765(01)00349-5","volume":"8","author":"T Kahyo","year":"2001","unstructured":"Kahyo T, Nishida T, Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell. 2001;8:713\u20138.","journal-title":"Mol Cell"},{"key":"3740_CR64","doi-asserted-by":"crossref","first-page":"16586","DOI":"10.1073\/pnas.1417548111","volume":"111","author":"HB Luo","year":"2014","unstructured":"Luo HB, Xia YY, Shu XJ, Liu ZC, Feng Y, Liu XH, et al. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc Natl Acad Sci USA. 2014;111:16586\u201391.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3740_CR65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1874091X00802010067","volume":"2","author":"L Eun Jeoung","year":"2008","unstructured":"Eun Jeoung L, Sung Hee H, Jaesun C, Sung Hwa S, Kwang Hum Y, Min Kyoung K, et al. Regulation of glycogen synthase kinase 3beta functions by modification of the small ubiquitin-like modifier. Open Biochem J. 2008;2:67\u201376.","journal-title":"Open Biochem J"},{"key":"3740_CR66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/adt.2006.029","volume":"5","author":"A Baki","year":"2007","unstructured":"Baki A, Bielik A, Molnar L, Szendrei G, Keseru GM. A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors. Assay Drug Dev Technol. 2007;5:75\u201383.","journal-title":"Assay Drug Dev Technol"},{"key":"3740_CR67","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrd2111","volume":"6","author":"MP Mazanetz","year":"2007","unstructured":"Mazanetz MP, Fischer PM. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat Rev Drug Discov. 2007;6:464\u201379.","journal-title":"Nat Rev Drug Discov"},{"key":"3740_CR68","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S, Lipton SA, Xu H. Oligomeric Abeta-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:48.","journal-title":"Mol Neurodegener"},{"key":"3740_CR69","volume":"39","author":"H Wada","year":"2024","unstructured":"Wada H, Maruyama T, Niikura T. SUMO1 modification of 0N4R-tau is regulated by PIASx, SENP1, SENP2, and TRIM11. Biochem Biophys Rep. 2024;39:101800.","journal-title":"Biochem Biophys Rep"},{"key":"3740_CR70","volume":"30","author":"J Zhao","year":"2024","unstructured":"Zhao J, Wei M, Guo M, Wang M, Niu H, Xu T, et al. GSK3: A potential target and pending issues for treatment of Alzheimer\u2019s disease. CNS Neurosci Ther. 2024;30:e14818.","journal-title":"CNS Neurosci Ther"},{"key":"3740_CR71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1083\/jcb.200301115","volume":"163","author":"MS Lee","year":"2003","unstructured":"Lee MS, Kao SC, Lemere CA, Xia W, Tseng HC, Zhou Y, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003;163:83\u201395.","journal-title":"J Cell Biol"},{"key":"3740_CR72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/ijms21010209","volume":"21","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chen D, Lee TH. Phosphorylation signaling in APP processing in Alzheimer\u2019s disease. Int J Mol Sci. 2019;21:209.","journal-title":"Int J Mol Sci"},{"key":"3740_CR73","volume":"78","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Li S, Li M, Ke D, Wang Q, Yang Y, et al. Human tau accumulation promotes glycogen synthase kinase-3\u03b2 acetylation and thus upregulates the kinase: A vicious cycle in Alzheimer neurodegeneration. EBioMedicine. 2022;78:103970.","journal-title":"EBioMedicine"},{"key":"3740_CR74","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41392-020-00290-9","volume":"5","author":"XY Hong","year":"2020","unstructured":"Hong XY, Wan HL, Li T, Zhang BG, Li XG, Wang X, et al. STAT3 ameliorates cognitive deficits by positively regulating the expression of NMDARs in a mouse model of FTDP-17. Signal Transduct Target Ther. 2020;5:295.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03740-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03740-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03740-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:02:35Z","timestamp":1793833355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03740-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["3740"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03740-y","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Human sample collection and experimental procedures strictly adhered to national regulations and international ethical guidelines, including the Declaration of Helsinki, and were conducted in accordance with standardized protocols established by the China Human Brain Banking Consortium. Written informed consent was obtained from all donors or their next of kin. The collection of specimens was approved by the Ethics Committee of Peking Union Medical College (Approval No. 009-2014), and the study utilizing human tissues was approved by the Human Ethics Committee of Union Hospital, Huazhong University of Science and Technology (Approval No. 2025-1300). All animal experiments were approved by the Institutional Animal Care and Use Committee of Huazhong University of Science and Technology (Approval No. 2023-4474).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable. This manuscript does not contain any identifiable images or clinical data of individual human research participants.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}